Enterprise League logo

Product

CXCR4-TSB

BIOTECHNOLOGY

byCardivia Labs Inc

United States (US)

ABOUT THE PRODUCT

A Target-Site Blocker (TSB) targeting CXCR4, designed to reprogram endothelial and smooth muscle cells to combat atherosclerosis.

Information is owner-confirmed

Last updated 4 days ago

Price range
N/A

Other products/services from Cardivia Labs Inc